VaxInnate Licenses Recombinant H1N1 Pandemic Swine Flu Vaccine To Biological E.; Vaccine Could Become Available For Use In India This Year
VaxInnate Corporation announced that it has granted Indian biopharmaceutical company Biological E. Limited a license to its recombinant H1N1 pandemic swine flu vaccine and is collaborating to facilitate the manufacture, clinical development and commercialization of the vaccine in India…
Related Posts
Tags: available, become, biological, efficacy, h1n1, india, licenses, pandemic, recombinant, swine, this, vaccine, vaxinnate, year
This entry was posted on Saturday, January 16th, 2010 at 8:01 am and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.



